Economic evaluation: what are we looking for and how do we get there?

Area of Science:

• Health Economics
• Pharmacoeconomics
• Haematology

Background:

• Growing interest in economic evaluations for haemophilia treatment strategies.
• Limited existing studies, primarily simple cost-minimization or cost-effectiveness analyses.
• Severe haemophilia necessitates lifelong treatment with varying short- and long-term effects.

Purpose of the Study:

• To discuss the advantages and disadvantages of different economic evaluation methods.
• To outline the data requirements for these methods in the context of severe haemophilia.
• To address challenges in data generation for treatment strategy comparisons.

Main Methods:

• Review of economic evaluation methodologies.
• Analysis of data requirements for comparing haemophilia treatment strategies (prophylaxis vs. on-demand).
• Discussion of data generation challenges and potential solutions.

Main Results:

• Economic evaluation of haemophilia treatment is complex due to the disease's chronic nature and differing treatment effects.
• Significant data are required for any chosen economic evaluation method.
• Challenges exist in acquiring comprehensive and relevant data for robust analyses.

Conclusions:

• Comparing haemophilia treatment strategies requires sophisticated economic evaluations.
• Addressing data gaps and methodological challenges is crucial for accurate economic assessments.
• Further research into data generation is needed to inform optimal treatment decisions.